Stiefel, a GSK company, Receives FDA Approval of Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%

Research Triangle Park, N.C. – July 16, 2010 – Stiefel, a GSK company, today announced that the U.S

Excerpt from:
Stiefel, a GSK company, Receives FDA Approval of Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%

Related posts:

1. Regulatory update – Stiefel, a GSK company, files NDA for tazarotene foam Stiefel, a GSK company, announced today that it has submitted...
2. News From the FDA The Food and Drug Administration has approved Veltin, gel containing...
3. FDA OKs Stiefel’s Veltin for treatment of acne Durham, N.C. ...
4. Medicis Announces Approval of New Strengths of SOLODYN(R) SCOTTSDALE, Ariz., July 27, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX)...
5. Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical… To the Editor: Combination benzoyl peroxide (BPO) and clindamycin (CL)...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message